ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PLPL Plandai Biotechnology Inc (PK)

0.0001
0.00 (0.00%)
Last Updated: 12:31:57
Delayed by 15 minutes
Share Name Share Symbol Market Type
Plandai Biotechnology Inc (PK) USOTC:PLPL OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0001 0.0001 0.0002 0.0001 0.0001 0.0001 4,804,500 12:31:57

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

31/01/2017 9:18pm

Edgar (US Regulatory)


 

 

OMB APPROVAL
OMB Number: 3235-0167
Expires: March 31, 2018
Estimated average burden hours per response ... 1.50
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 000-51206

 

Plandai Biotechnology, Inc.

(Exact name of registrant as specified in its charter)

 

17 Hanover Square London England, W1S 1BN  (917) 900-6829

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

 

Common Stock

(Title of each class of securities covered by this Form)

 


(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)          

Rule 12g-4(a)(2)
Rule 12h-3(b)(1)(i) ☐ 
Rule 12h-3(b)(2)(ii)   ☐ 
Rule 15d-6 ☐ 
Rule 15d-22(b)  ☐ 

  

Approximate number of holders of record as of the certification or notice date: 147

 

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: January 31, 2017 By: /s/ Roger Baylis - Duffield

 

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 

SEC 2069 (08-11)

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1

1 Year Plandai Biotechnology (PK) Chart

1 Year Plandai Biotechnology (PK) Chart

1 Month Plandai Biotechnology (PK) Chart

1 Month Plandai Biotechnology (PK) Chart

Your Recent History

Delayed Upgrade Clock